38791-62-7

Basic information

• Product Name: 4-PHENOXYPHTHALONITRILE
• Synonyms: 4-PHENOXYPHTHALONITRILE;4-Phenoxy-1,2-benzenedicarbonitrile;NSC 646245;4-phenoxybenzene-1,2-dinitrile
• CAS NO: 38791-62-7
• Molecular Formula: C₁₄H₈N₂O
• Molecular Weight: 220.23
• Product Categories: P;Stains and Dyes;Stains&Dyes, A to
• Mol File: 38791-62-7.mol
• Article Data: 17

Chemical Properties

• Melting Point: 98-100 °C(lit.)
• Boiling Point: 399.8°C at 760 mmHg
• Flash Point: 166.1°C
• Appearance: /
• Density: 1.24g/cm³
• Vapor Pressure: 1.33E-06mmHg at 25°C
• Refractive Index: 1.625
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-PHENOXYPHTHALONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-PHENOXYPHTHALONITRILE(38791-62-7)
• EPA Substance Registry System: 4-PHENOXYPHTHALONITRILE(38791-62-7)

Safety Data

• Hazard Codes: Xn
• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 38791-62-7(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 38791-62-7 differently. You can refer to the following data:
1. 4-Phenoxyphthalonitrile is a C4-substituted phthalonitrile with monoamine oxidase inhibitory activity. 4-Phenoxyphthalonitrile is used in organic pigments and dyes.
2. 4-Phenoxyphthalonitrile is a C4-substituted phthalonitrile with monoamine oxidase inhibitory activity. 4-Phenoxyphthalonitrile is used in organic pigments and dyes. Dyes and metabolites.

InChI:InChI=1/C14H8N2O/c15-9-11-6-7-14(8-12(11)10-16)17-13-4-2-1-3-5-13/h1-8H

Upstream product

• 31643-49-9 4-Nitrophthalonitrile 
• 108-95-2 phenol 
• 139-02-6 sodium phenoxide 

Downstream Products

• 147699-63-6 1,2-diisocyano-3,4-diphenoxy benzene 
• 1421312-36-8 [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)amino]acetic acid methyl ester 
• 1421312-35-7 4-hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid 
• 1421312-34-6 4-hydroxy-1-methyl-7-phenoxyisoquinolinyl-3-carboxylic acid methyl ester 
• 1421312-33-5 methyl 4-hydroxy-1-chloro-7-phenoxyisoquinoline-3-carboxylate 
• 1421312-32-4 C₁₇H₁₃NO₅ 
• 1421312-31-3 C₁₈H₁₃NO₆ 
• 21345-01-7 4-phenoxyphthalic anhydride 
• 37951-15-8 4-phenoxyphthalic acid 
• 808118-40-3 [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid 
• 1236228-97-9 β-phenothiazinyl-tri(β-phenoxy) zinc phthalocyanine 
• 77447-46-2 cobalt(II) tetra-4-(C₆H₅O)-phthalocyanine 
• 77447-50-8 Cu(C₈H₃N₂OC₆H₅)4 
• 77447-45-1 Zn(phthalocyanine(OPh)4) 

Relevant articles and documents

Titanyl phthalocyanine and its soluble derivatives: Highly efficient photosensitizers for singlet oxygen production

The photophysical properties of titanyl phthalocyanine (TiOPc), tetra(β-phenoxy) titanyl phthalocyanine (TiOPc(β-OPh)4) and tetra(α-phenoxy) titanyl phthalocyanine (TiOPc(α-OPh)4), were investigated in homogeneous solution. Absorptio

Synthesis and structural characterization of Cr(III) complex of porphyrazine and phthalocyanine derivatives: Kinetic studies of metalation and redox activity

Chromium(III) complexes of 2,3,7,8,12,13,17,18-octakis(propyl)porphyrazine and 2,3,9,10,16,17,23,24-octa substituted phthalocyanine were synthesized, characterized and the kinetics of metalation and redox activity studied and reported. The results obtained indicated that the rate of incorporation of Cr(III) into the central cavity of the ligands is a function of the kinetic inertness and size of the metal ion as well as the peripheral substituents of the ligand. The Cr(III) complex of 2,3,7,8,12,13,17,18-octakis(propyl)porphyrazine exhibited a metal based reduction. Hence it was concluded that the nature of the incorporated metal ions has an influence on the rate and mechanism of incorporation of the metal ion and also the redox activities of these complexes.

CRYSTAL TYPES OF COMPOUNDS INHIBITING ACTIVITY OF PROLYL HYDROXYLASE AND USE THEREOF

The invention relates to crystal types of compound shown as structural formula I, methods of preparing the compound, intermediate, pharmaceutical composition, and use of treating disease or pharmaceutical preparations for treating disease.